Ulisse Biomed S.p.A. (BIT:UBM)
Italy
· Delayed Price · Currency is EUR 0.7600
-0.0140 (-1.81%)
Jun 27, 2025, 4:33 PM CET
Ulisse Biomed Revenue
In the year 2024, Ulisse Biomed had annual revenue of 767.93K EUR with 1,059.87% growth. Ulisse Biomed had revenue of 397.07K in the half year ending December 31, 2024, with 431.07% growth.
Revenue
767.93K
Revenue Growth
+1,059.87%
P/S Ratio
24.23
Revenue / Employee
34.91K
Employees
22
Market Cap
18.61M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.41B |
| DiaSorin | 1.21B |
| Amplifon | 2.42B |
| Philogen | 77.65M |
| EL.En. | 577.19M |
| Garofalo Health Care | 470.20M |
| Pharmanutra | 116.15M |
| Safilo Group | 993.22M |